Clinician's Roundtable

Host: Leslie P. Lundt, MD

Guest: Stuart McGill, PhD

How might back pain be prevented? Dr. Stuart McGill, professor of spine biomechanics and chair of the Department of Kinesiology at the University of Waterloo, shares his research with host Dr. Leslie Lundt regarding the mechanisms of back injury. A greater understanding of these mechanisms can help patients prevent back pain and injuries. They discuss twisting, lifting, disk hydration and stabilization. In addition, Dr. McGill talks about spine research observing athletes and their spines as they come in and out of the game.

Host: Leslie P. Lundt, MD

Guest: Stuart McGill, PhD

Each year, 40 to 60 percent of American adults suffer from chronic back pain. More than one million spine surgery procedures are performed annually in the US, with medical costs to treat back pain approaching $24 billion per year. Dr. Stuart McGill, professor of spine biomechanics and chair of the department of kinesiology at the University of Waterloo in Ontario, Canada, joins host Dr. Leslie Lundt to talk about cost-effective treatments for back pain.

Host: Leslie P. Lundt, MD

Guest: Stuart McGill, PhD

At some point nearly 85% of your patients below age 50 will present with back pain and nearly all of them will have at least one recurrence. Host Dr. Leslie Lundt welcomes Dr. Stuart McGill, professor of spine biomechanics and chair of the Department of Kinesiology at the University of Waterloo to review the primary causes of back pain.

Host: Leslie P. Lundt, MD

Guest: Matthew W. Johnson, PhD

It used to be common for researchers to study the potential medicinal uses for hallucinogenic drugs, including psilocybin, ecstasy, and LSD; however, the 60's left a blemish on legitimate research and it grinded to a halt. Host Dr. Leslie Lundt welcomes Dr. Matthew Johnson, a psychopharmacologist in the Department of Psychiatry at the Johns Hopkins School of Medicine, who is studying psychoactive drug effects in human participants.

Host: Leslie P. Lundt, MD

Guest: Peter R. Breggin, MD

Our guest Dr. Peter Breggin, a psychiatrist now in private practice in Ithica New York has been convinced by the weight of scientific evidence and his years of clinical experience that psychiatric medications frequently cause patients to lose their judgment and their ability to control their emotions and actions. Needless to say, he is a controversial figure in our field. He joins host Dr. Leslie Lundt to discuss why he believes that psychotropics "spellbind" patients.

Host: Leslie P. Lundt, MD

Guest: Roger McIntyre, MD

It is reported that up to a fifth of bipolar disorder patients will commit suicide, yet there are few studies looking at clinical risk factors in this population. What is the latest research? Host Dr. Leslie Lundt welcomes Dr. Roger McIntyre, associate professor of psychiatry and pharmacology at the University of Toronto School of Medicine, to discuss his latest research investigating childhood abuse with adult bipolar suicide rates.

Host: Leslie P. Lundt, MD

Guest: Matthew W. Johnson, PhD

It used to be common for researchers to study the potential medicinal uses for hallucinogenic drugs, including psilocybin, ecstasy, and LSD; however, the 60's left a blemish on legitimate research and it grinded to a halt. Host Dr. Leslie Lundt welcomes Dr. Matthew Johnson, a psychopharmacologist in the Department of Psychiatry at the Johns Hopkins School of Medicine, who is studying psychoactive drug effects in human participants.

Host: Bruce Japsen

Guest: Peter Farrell

Point-of-care testing has evolved in the last decade, allowing for immediate diagnostic testing at a patient's bedside. But a new study points to perhaps some usages and healthcare benefits not previously realized, particularly in the emergency room. Peter Farrell, divisional vice president of marketing and clinical affairs for Abbott Laboratories Point of Care business tells the Chicago Tribune's Bruce Japsen about the importance of point of care testing, which essentially puts diagnostic testing in the physicians' hands.

Host: Bruce Japsen

Guest: Peter Farrell

Some doctors may view it as a laboratory in their hand - the new point-of-care method of diagnostic testing, right at the patients bedside. Peter Farrell, divisional vice president of marketing and clinical affairs for Abbott Laboratories Point-of-Care business, tells the Chicago Tribune's Bruce Japsen about the movement of hospitals, doctors and other health facilities to point-of-care testing, which allows for quicker diagnoses and subsequent treatment plans.

Host: Maurice Pickard, MD

Guest: James L. Gulley, MD, PhD, FACP

Can a vaccination help prevent prostate cancer? Dr. James Gulley, director of the Clinical Trials Group of the Laboratory of Tumor Immunology and Biology at the National Institutes of Health discusses studies involving the use of cancer vaccines to modulate the immune response in cancer patients. These trials contrast classic "tumor response" with "patient response" that have shown increased survival post therapy.